Supplementary Figure 10: Positive and negative controls of RIP experiments.
From: Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer
Left, RIP–qPCR of R34 by hnRNPL pulldown. R34 was found to interact with hnRNPL by a RIP-seq screening analysis (unpublished data) and is used as a positive control here. Right, RIP–qPCR of PCAT1 by YY1 pulldown. Antibody to YY1 was used as a negative-control antibody for RIP.
